[Pharmacokinetics, pharmacodynamics, and tissue distribution of oral co-loaded puerarin/daidzein mixed micelles in rats]. 2023

Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
School of Modern Chinese Medicine and Pharmaceutical Industry, Jiangxi University of Chinese Medicine Nanchang 330004, China.

This study investigated the drug delivery performance of oral co-loaded puerarin(PUE) and daidzein(DAZ) mixed micelles(PUE/DAZ-FS/PMMs) from the perspectives of pharmacokinetics, pharmacodynamics, and tissue distribution. The changes in PUE plasma concentration in rats were evaluated based on PUE suspension, single drug-loaded micelles(PUE-FS/PMMs), and co-loaded micelles(PUE/DAZ-FS/PMMs). Spontaneously hypertensive rats(SHR) were used to monitor systolic blood pressure, diastolic blood pressure, and mean arterial pressure for 10 weeks after administration by tail volume manometry. The content of PUE in the heart, liver, spleen, lung, kidney, brain, and testes was determined using LC-MS/MS. The results showed that compared with PUE suspension and PUE-FS/PMMs, PUE/DAZ-FS/PMMs significantly increased C_(max) in rats(P<0.01) and had a relative bioavailability of 122%. The C_(max), AUC_(0-t), AUC_(0-∞), t_(1/2), and MRT of PUE/DAZ-FS/PMMs were 1.77, 1.22, 1.22, 1.17, and 1.13 times higher than those of PUE suspension, and 1.76, 1.16, 1.08, 0.84, and 0.78 times higher than those of PUE-FS/PMMs, respectively. Compared with the model control group, PUE/DAZ-FS/PMMs significantly reduced systolic blood pressure, diastolic blood pressure, and mean arterial pressure in SHR rats(P<0.05). The antihypertensive effect of PUE/DAZ-FS/PMMs was greater than that of PUE suspension, and even greater than that of PUE-FS/PMMs at high doses. Additionally, the distribution of PMMs in various tissues showed dose dependency. The distribution of PMMs in the kidney and liver, which are metabolically related tissues, was lower than that in the suspension group, while the distribution in the brain was higher than that in the conventional dose group. In conclusion, PUE/DAZ-FS/PMMs not only improved the bioavailability of PUE and synergistically enhanced its therapeutic effect but also prolonged the elimination of the drug to some extent. Furthermore, the micelles facilitated drug penetration through the blood-brain barrier. This study provides a foundation for the development of co-loaded mixed micelles containing homologous components.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
January 2021, AAPS PharmSciTech,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
June 2017, Molecules (Basel, Switzerland),
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
March 2020, Pharmaceutical development and technology,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
May 2011, International journal of pharmaceutics,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
February 2020, Pharmaceutics,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
January 2015, Cell biochemistry and biophysics,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
April 2006, Drug development and industrial pharmacy,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
January 2015, Turkish journal of medical sciences,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
January 2012, International journal of nanomedicine,
Wen-Ting Wu, and Zi-Lu Guo, and Shu-Chao Ge, and Wen-Liang Kuang, and Wen-Dong Li, and Shang-Dian Wang, and Peng Liu, and Zhi-Wei Zhou, and Wei-Feng Zhu
June 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!